Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
The Axcelis Technologies Inc (ACLS) news page on Stock Titan aggregates company announcements, industry event participation and regulatory disclosures focused on its role in the semiconductor equipment market. Axcelis describes itself as a leading supplier of enabling ion implantation solutions for the semiconductor industry, with more than 45 years of experience providing high-productivity systems and lifecycle support.
Investors and industry followers can use this page to monitor Axcelis’ updates on product launches, technology platforms and market engagement. Recent news has highlighted the introduction of the Purion Power Series+ ion implant platform for next generation power devices, including silicon carbide (SiC) power devices and superjunction architectures, as well as the GSD Ovation ES high current implanter for engineered substrates. Company releases also cover its participation in major industry events such as SEMICON Japan and the International Conference on Silicon Carbide and Related Materials (ICSCRM), where Axcelis technologists present technical work on SiC and related materials.
The feed also includes financial and corporate developments, such as quarterly results announcements, conference call schedules and Axcelis’ participation in investor conferences. A significant recent development is the all-stock merger agreement with Veeco Instruments Inc., under which Veeco is expected to become a wholly owned subsidiary of Axcelis, subject to regulatory and shareholder approvals.
By following this ACLS news page, readers can track Axcelis’ communications on its ion implantation product portfolio, aftermarket strategy, global customer engagement and planned combination with Veeco, all drawn from official press releases and SEC-referenced materials.
Axcelis Technologies (NASDAQ: ACLS) is set to participate in the 14th Annual CEO Summit on July 13, 2022, taking place at the St. Regis Hotel in San Francisco, CA. This event allows accredited investors and research analysts to engage with the management teams of various participating companies. Axcelis, a leader in ion implantation solutions for the semiconductor industry, will make presentation materials available on its investor page. Early RSVP is advised as space is limited, with the registration deadline on July 1, 2022.
Axcelis Technologies (Nasdaq: ACLS) reported multiple shipments of Purion M™ medium current implanters, enhancing its presence in the semiconductor industry. These include follow-on orders and three new placements across the US, Europe, and Asia, shipped in Q2 2022. Executive VP Bill Bintz noted that the mature process technology market continues to be robust, indicating potential revenue growth from these new tool placements. This strategic move aims to expand the company's customer base and revenues in a vital segment of the industry.
Axcelis Technologies (NASDAQ: ACLS) has announced its participation in several upcoming investor conferences. Key events include the 22nd Annual B. Riley Institutional Investor Conference on May 25 in Beverly Hills, CA, featuring a fireside chat by management. Other conferences include the Craig-Hallum Institutional Investor Conference on June 1, the Cowen Technology, Media & Telecom Conference on June 2, and the Stifel 2022 Cross Sector Insight Conference on June 8, where management will also present and conduct meetings. A live webcast will be available for the Stifel event.
Axcelis Technologies reported strong first-quarter results for 2022, with revenue of $203.6 million, slightly down from Q4 2021. The company achieved an operating profit of $48.9 million and net income of $41.6 million, or $1.22 per diluted share. A record backlog of $625.1 million and bookings of $315.5 million were reported, alongside cash of $297.9 million. The company anticipates exceeding $850 million in revenue for 2022. Despite supply chain challenges affecting margins, an optimistic outlook for the second quarter predicts revenues between $205-215 million.
Axcelis Technologies (Nasdaq: ACLS) announced the shipment of two Purion H™ high current implanter evaluation systems in Q2 2022 to major chipmakers in Asia. These systems will assist in the production of DRAM memory and mature process technology devices. President and CEO Mary Puma highlighted the growth opportunities presented by these installations, emphasizing the superior process control and productivity offered by the Purion H technology.
Axcelis Technologies (Nasdaq: ACLS), headquartered in Beverly, Mass., announced multiple shipments of its Purion Dragon™ high current implanter to semiconductor manufacturers in Asia, including follow-on orders and new customers. The Purion Dragon features advanced orthogonal beam optics tailored for critical implant steps in advanced memory and logic applications. This shipment, occurring in the first and second quarters of 2022, supports existing customer capacity expansion and marks entry into new markets. Executive VP Bill Bintz emphasized the implanter's capabilities and the productivity gains it delivers.
Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its financial results for the first quarter of 2022 on May 4, 2022, at 4:00 p.m. ET. Following this, the company will host a conference call on May 5, 2022, at 8:30 a.m. ET, accessible via an audio webcast on its Investors page. Interested parties can join the call by dialing in at least 15 minutes prior to ensure connection. The company specializes in high-productivity solutions for the semiconductor industry, particularly in ion implantation systems.
On March 31, 2022, Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of its Purion XE™ and Purion M™ implanters to a major power device chipmaker in Japan. These systems are meant for the high-volume production of 300mm thin silicon wafer-based MOSFET and IGBT devices used in automotive and power management applications. Executive VP Bill Bintz stated that the Purion Power Series' unique capabilities position Axcelis for growth in this market and they aim to enhance their footprint in Japan.
Axcelis Technologies (Nasdaq: ACLS) announced several shipments of its Purion VXE high-energy systems to top CMOS image sensor manufacturers in Asia.
The Purion VXE, an advanced energy solution, is now recognized as the process tool of record in the image sensor sector. CEO Mary Puma highlighted that Axcelis holds a strong position in the growing image sensor market, which benefits from trends in IoT, mobile, and automotive sectors.
On March 1, 2022, Axcelis Technologies (Nasdaq: ACLS) announced a new $100 million share repurchase program, funded by available working capital. This initiative reflects the Board's confidence in the company's long-term growth prospects. Since 2019, Axcelis has returned over $75 million to shareholders. Buybacks will occur under SEC Rule 10b-18, subject to market conditions, and the company may suspend the program at any time. Management emphasizes that while this is a positive step, it remains cautious due to potential risks.